Effects of Process and Design Parameters on Granule Size Distribution in a Continuous High Shear Granulation Process

Wei Meng, Sarang Oka, Xue Liu, Thamer Omer, Rohit Ramachandran, Fernando Muzzio

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Purpose: Wet granulation is widely used in the pharmaceutical industry. This advantageous technology is capable of enhancing compression and powder handling, decreasing ingredient segregation, and promoting blend and content uniformity. Currently, a high level of interest exists in the continuous version of this technology, both by the US Food and Drug Administration (FDA), and by pharmaceutical manufacturers. Methods: In this paper, a continuous high shear wet granulation process was examined based on a placebo formulation comprising 70% ∂-lactose monohydrate and 30% microcrystalline cellulose (Avicel® PH101). Granulation was then carried out in a continuous high shear mixer granulator, Glatt GCG 70. The impact of two process variables (rotation speed and liquid/solid (L/S) ratio) and two design parameters (blade configuration and nozzle position) were evaluated via an I-optimal design. Results: Multi-factor analysis of variance (ANOVA) indicated that rotation speed and L/S ratio dominated the granulation process and had the most significant effects on granule size distribution (GSD). The largest granule mass median diameter was obtained at the lowest rotation speed and highest L/S ratio. The granulation mechanism underlying this continuous process was examined using a wetting and nucleation regime map. For the cases studied here, the mechanical dispersion regime controlled the formation of granule nuclei, leading to a broad GSD and a limited growth ratio.

Original languageEnglish (US)
Pages (from-to)283-295
Number of pages13
JournalJournal of Pharmaceutical Innovation
Volume12
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Technology
Drug Industry
United States Food and Drug Administration
Lactose
Cellulose
Powders
Statistical Factor Analysis
Analysis of Variance
Placebos
Growth
Pharmaceutical Preparations
microcrystalline cellulose

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science
  • Drug Discovery

Keywords

  • Continuous manufacturing
  • Design of experiments
  • Granule size distribution
  • High shear granulation
  • Quality by design
  • Regime map

Cite this

@article{3067492dfd3d49e592d935175e5f6986,
title = "Effects of Process and Design Parameters on Granule Size Distribution in a Continuous High Shear Granulation Process",
abstract = "Purpose: Wet granulation is widely used in the pharmaceutical industry. This advantageous technology is capable of enhancing compression and powder handling, decreasing ingredient segregation, and promoting blend and content uniformity. Currently, a high level of interest exists in the continuous version of this technology, both by the US Food and Drug Administration (FDA), and by pharmaceutical manufacturers. Methods: In this paper, a continuous high shear wet granulation process was examined based on a placebo formulation comprising 70{\%} ∂-lactose monohydrate and 30{\%} microcrystalline cellulose (Avicel{\circledR} PH101). Granulation was then carried out in a continuous high shear mixer granulator, Glatt GCG 70. The impact of two process variables (rotation speed and liquid/solid (L/S) ratio) and two design parameters (blade configuration and nozzle position) were evaluated via an I-optimal design. Results: Multi-factor analysis of variance (ANOVA) indicated that rotation speed and L/S ratio dominated the granulation process and had the most significant effects on granule size distribution (GSD). The largest granule mass median diameter was obtained at the lowest rotation speed and highest L/S ratio. The granulation mechanism underlying this continuous process was examined using a wetting and nucleation regime map. For the cases studied here, the mechanical dispersion regime controlled the formation of granule nuclei, leading to a broad GSD and a limited growth ratio.",
keywords = "Continuous manufacturing, Design of experiments, Granule size distribution, High shear granulation, Quality by design, Regime map",
author = "Wei Meng and Sarang Oka and Xue Liu and Thamer Omer and Rohit Ramachandran and Fernando Muzzio",
year = "2017",
month = "12",
day = "1",
doi = "10.1007/s12247-017-9288-7",
language = "English (US)",
volume = "12",
pages = "283--295",
journal = "AAPS PharmSciTech",
issn = "1530-9932",
publisher = "American Association of Pharmaceutical Scientists",
number = "4",

}

Effects of Process and Design Parameters on Granule Size Distribution in a Continuous High Shear Granulation Process. / Meng, Wei; Oka, Sarang; Liu, Xue; Omer, Thamer; Ramachandran, Rohit; Muzzio, Fernando.

In: Journal of Pharmaceutical Innovation, Vol. 12, No. 4, 01.12.2017, p. 283-295.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effects of Process and Design Parameters on Granule Size Distribution in a Continuous High Shear Granulation Process

AU - Meng, Wei

AU - Oka, Sarang

AU - Liu, Xue

AU - Omer, Thamer

AU - Ramachandran, Rohit

AU - Muzzio, Fernando

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Purpose: Wet granulation is widely used in the pharmaceutical industry. This advantageous technology is capable of enhancing compression and powder handling, decreasing ingredient segregation, and promoting blend and content uniformity. Currently, a high level of interest exists in the continuous version of this technology, both by the US Food and Drug Administration (FDA), and by pharmaceutical manufacturers. Methods: In this paper, a continuous high shear wet granulation process was examined based on a placebo formulation comprising 70% ∂-lactose monohydrate and 30% microcrystalline cellulose (Avicel® PH101). Granulation was then carried out in a continuous high shear mixer granulator, Glatt GCG 70. The impact of two process variables (rotation speed and liquid/solid (L/S) ratio) and two design parameters (blade configuration and nozzle position) were evaluated via an I-optimal design. Results: Multi-factor analysis of variance (ANOVA) indicated that rotation speed and L/S ratio dominated the granulation process and had the most significant effects on granule size distribution (GSD). The largest granule mass median diameter was obtained at the lowest rotation speed and highest L/S ratio. The granulation mechanism underlying this continuous process was examined using a wetting and nucleation regime map. For the cases studied here, the mechanical dispersion regime controlled the formation of granule nuclei, leading to a broad GSD and a limited growth ratio.

AB - Purpose: Wet granulation is widely used in the pharmaceutical industry. This advantageous technology is capable of enhancing compression and powder handling, decreasing ingredient segregation, and promoting blend and content uniformity. Currently, a high level of interest exists in the continuous version of this technology, both by the US Food and Drug Administration (FDA), and by pharmaceutical manufacturers. Methods: In this paper, a continuous high shear wet granulation process was examined based on a placebo formulation comprising 70% ∂-lactose monohydrate and 30% microcrystalline cellulose (Avicel® PH101). Granulation was then carried out in a continuous high shear mixer granulator, Glatt GCG 70. The impact of two process variables (rotation speed and liquid/solid (L/S) ratio) and two design parameters (blade configuration and nozzle position) were evaluated via an I-optimal design. Results: Multi-factor analysis of variance (ANOVA) indicated that rotation speed and L/S ratio dominated the granulation process and had the most significant effects on granule size distribution (GSD). The largest granule mass median diameter was obtained at the lowest rotation speed and highest L/S ratio. The granulation mechanism underlying this continuous process was examined using a wetting and nucleation regime map. For the cases studied here, the mechanical dispersion regime controlled the formation of granule nuclei, leading to a broad GSD and a limited growth ratio.

KW - Continuous manufacturing

KW - Design of experiments

KW - Granule size distribution

KW - High shear granulation

KW - Quality by design

KW - Regime map

UR - http://www.scopus.com/inward/record.url?scp=85020293080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020293080&partnerID=8YFLogxK

U2 - 10.1007/s12247-017-9288-7

DO - 10.1007/s12247-017-9288-7

M3 - Article

AN - SCOPUS:85020293080

VL - 12

SP - 283

EP - 295

JO - AAPS PharmSciTech

JF - AAPS PharmSciTech

SN - 1530-9932

IS - 4

ER -